Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107674

Isolation and Characterization of an Abnormal Human Intrinsic Factor

Max Katz, Carol S. Mehlman, and Robert H. Allen

Division of Hematology, Royal Victoria Hospital, and the Department of Experimental Medicine, McGill University, Montreal, Canada

Division of Hematology-Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Katz, M. in: JCI | PubMed | Google Scholar

Division of Hematology, Royal Victoria Hospital, and the Department of Experimental Medicine, McGill University, Montreal, Canada

Division of Hematology-Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Mehlman, C. in: JCI | PubMed | Google Scholar

Division of Hematology, Royal Victoria Hospital, and the Department of Experimental Medicine, McGill University, Montreal, Canada

Division of Hematology-Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

Find articles by Allen, R. in: JCI | PubMed | Google Scholar

Published May 1, 1974 - More info

Published in Volume 53, Issue 5 on May 1, 1974
J Clin Invest. 1974;53(5):1274–1283. https://doi.org/10.1172/JCI107674.
© 1974 The American Society for Clinical Investigation
Published May 1, 1974 - Version history
View PDF
Abstract

A patient has been described previously who presented at age 13 with vitamin B12 (B12) deficiency secondary to a functionally abnormal intrinsic factor (IF). IF has now been isolated from the gastric juice of the patient, his sister, and both parents, who are first cousins, by using affinity chromatography on B12-Sepharose. Patient IF appeared normal in terms of (a) B12 binding, (b) mol wt, (c) total amino acid and carbohydrate composition, and (d) immunodiffusion with rabbit anti-patient and anti-normal IF sera. After adsorption with normal IF, however, anti-patient IF serum precipitated the various IFs as follows: patient IF (> 95%); mother, father, and sister IF (50%); and normal IF (< 10%). Additional adsorption with mother, father, or sister IF completely inhibited the precipitation of patient IF. The association constant determined for patient IF-B12 and human ileal mucosal homogenates (0.1 × 109 M-1) was 60-fold lower than that determined with normal IF-B12 (6.0 × 109 M-1). Intermediate amounts of ileal IF-B12 binding were observed with mother, father, and sister IF-B12. These in vitro studies were supported by multiple Schilling tests, performed with a totally gastrectomized volunteer, that gave the following mean urinary excretions of [57Co]B12: free B12 (0.5%); + patient gastric juice (2.6%); + mother or father gastric juice (17%); and + normal gastric juice (26%). These studies demonstrate that the patient is homozygous and that the mother, father, and sister are heterozygous for a structurally abnormal IF that has a markedly decreased, but not absent, affinity for ileal IF-B12 receptors. These studies also indicate that the B12 and ileal binding sites are located on different portions of the IF molecule.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1274
page 1274
icon of scanned page 1275
page 1275
icon of scanned page 1276
page 1276
icon of scanned page 1277
page 1277
icon of scanned page 1278
page 1278
icon of scanned page 1279
page 1279
icon of scanned page 1280
page 1280
icon of scanned page 1281
page 1281
icon of scanned page 1282
page 1282
icon of scanned page 1283
page 1283
Version history
  • Version 1 (May 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts